Aap Implantate AG Reports 2024 Financial Results: Strong Operational Gains

aap Implantate AG has published its final audited consolidated financial statements for 2024, confirming a significant operational improvement. The company improved its Group EBITDA from EUR -3.4 million to EUR -0.85 million, corroborating preliminary results announced earlier in June.

The audited figures indicate a 6% rise in turnover to EUR 12.2 million and an 8% increase in gross margin to EUR 10.6 million. Operating profit (EBIT) improved by 64% to EUR -2.7 million, and net revenue losses decreased by 53% to EUR -3.7 million.

Moreover, aap significantly strengthened its financial position, with the equity ratio rising to 66% and interest-bearing liabilities reduced from EUR 4.6 million to EUR 0.9 million. The company's strategy of innovation and growth has set a firm foundation for continued resilience in a competitive market.